# A Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as Treatment for Gastric/GEJ Cancer

> **NCT07110571** · PHASE2 · RECRUITING · sponsor: **Suzhou Suncadia Biopharmaceuticals Co., Ltd.** · enrollment: 200 (estimated)

## Conditions studied

- Gastric Cancer
- Gastroesophageal-junction Cancer

## Interventions

- **DRUG:** Adebrelimab Injection
- **DRUG:** SHR-A1811 for Injection
- **DRUG:** SHR-A1904 for Injection
- **DRUG:** SHR-8068 Injection

## Key facts

- **NCT ID:** NCT07110571
- **Lead sponsor:** Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-28
- **Primary completion:** 2026-08
- **Final completion:** 2027-05
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07110571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07110571, "A Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as Treatment for Gastric/GEJ Cancer". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT07110571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*